PALO ALTO, Calif.--Incyte Pharmaceuticals this month released Unigem V, a sequence-verified gene expression microarray that contains nearly 10,000 DNA samples representing the majority of known human genes from public domain databases, as well as thousands of expressed sequence tags arrayed on a high-density grid. Sequence information for each clone in the microarray has been verified by Incyte to allow researchers to proceed directly from analysis of experiment data to testing individual clones. The company called the product a "powerful tool designed for life-science researchers working with publicly available gene sequence data."
The sequence verification in Unigem V gives researchers access to reliable data that are critical to identifying and validating promising gene targets; identifying previously unknown genes; and understanding the behavior of genes in both diseased and healthy cells, according to Incyte.
Incyte also recently released LifeTools 2.0, an enhanced version of its integrated bioinformatics software for enterprise-wide genomics research. LifeTools is a comprehensive, web-based software tool for managing and mining collections of genomic data from various databases, multiple data sources such as human expressed sequence tags and microbial sequencing projects, and data from different species. The software incorporates automated data management features, a real-time transactional data center, and a suite of sequence analysis tools.